Showing results (231-240 of 520) with videos related to
Sort By:
Pageof 52
Geriatrics (Basel, Switzerland)|March 18, 2020
Frailty Confers High Mortality Risk across Different Populations: Evidence from an Overview of Systematic Reviews and Meta-AnalysesRichard Ofori-Asenso, Ken Lee Chin, Berhe W Sahle, et al.Pharmacoeconomics|August 22, 2023
Lipid-Lowering Strategies for Primary Prevention of Coronary Heart Disease in the UK: A Cost-Effectiveness AnalysisJedidiah I Morton, Clara Marquina, Melanie Lloyd, et al.Diabetes Care|May 24, 2021
Projecting the Incidence of Type 2 Diabetes-Related End-Stage Kidney Disease Until 2040: A Comparison Between the Effects of Diabetes Prevention and the Effects of Diabetes TreatmentJedidiah I Morton, Stephen P McDonald, Agus Salim, et al.Inflammatory Bowel Diseases|July 7, 2021
Endoscopic Prediction of Crohn's Disease Postoperative RecurrencePeter De Cruz, Amy L Hamilton, Kathryn J Burrell, et al.Journal of Hypertension|November 6, 2009
Do COX-2 inhibitors raise blood pressure more than nonselective NSAIDs and placebo? An updated meta-analysisClara C Chan, Christopher M Reid, Tai-Juan Aw, et al.Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|March 15, 2014
Using WOMAC Index scores and personal characteristics to estimate Assessment of Quality of Life utility scores in people with hip and knee joint diseaseIlana N Ackerman, Mark A Tacey, Zanfina Ademi, et al.Transfusion|January 14, 2014
Predicting blood loss and transfusion requirement in patients undergoing surgery for musculoskeletal tumorsPhilip A Thompson, Deborah May, Peter F Choong, et al.Pharmacoeconomics|June 26, 2020
Novel Treatment Strategies for Secondary Prevention of Cardiovascular Disease: A Systematic Review of Cost-EffectivenessClara Marquina, Ella Zomer, Sandra Vargas-Torres, et al.Journal of Cardiovascular Pharmacology and Therapeutics|November 23, 2018
Dispensing Patterns of Blood Pressure Lowering Agents in Older Australians From 2006 to 2016Si Si, Richard Ofori-Asenso, Tom Briffa, et al.Mycoses|November 13, 2019
A population-based analysis of attributable hospitalisation costs of invasive fungal diseases in haematological malignancy patients using data linkage of state-wide registry and costing databases: 2009-2015Jake C Valentine, C Orla Morrissey, Mark A Tacey, et al.Pageof 52